Abbott Laboratories
NYSE:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbott Laboratories
NYSE:ABT
|
US |
|
Sika AG
SIX:SIKA
|
CH |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
T
|
Toray Industries Inc
DUS:TOR1
|
JP |
|
C
|
Constellation Software Inc
XBER:W9C
|
CA |
|
SSAB AB
LSE:0KII
|
SE |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
Aurelia Metals Ltd
ASX:AMI
|
AU |
|
K
|
Kelly Services Inc
XBER:KYSA
|
US |
|
Cleen Energy AG
F:ET1
|
AT |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT is 120.04 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
120.04
USD
According to Wall Street analysts, the average 1-year price target for
ABT is 120.04 USD with a low forecast of 92.92 USD and a high forecast of 142.8 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.